926P Real-world data in the era of immune checkpoint inhibitors (ICIs): Cetuximab-containing first-line therapy in patients with recurrent and/or metastatic head and neck squamous cell carcinoma
Saved in:
Published in | Annals of oncology Vol. 31; p. S667 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier Ltd
01.09.2020
|
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!